FDA gives green light to America Stem Cell transplant trial

09/5/2013 | American City Business Journals

The FDA has granted America Stem Cell approval to conduct a Phase I/IIa multicenter dual umbilical cord transplantation study. The nationwide trial will assess the efficacy of the firm's investigational therapy ASC-101 in patients with hematologic malignancies and myelodysplastic syndrome.

View Full Article in:

American City Business Journals

Published in Briefs:

SmartBrief Job Listings for Education

Job Title Company Location
Principal
Visible Men Academy
Bradenton, FL
Director, Department of Defense Dependents Schools, Europe
Department of Defense Education Activity (DoDEA)
Sembach
Senior Researcher\/Technical Assistance Consultant (8264)
American Institutes for Research
Washington, DC
K-12 Teachers Needed at Int’l Schools
The International Educator
Multiple Locations
Program Director, Education and Learning
Urban Libraries Council
Washington, DC